Edwards Lifesciences’ PASCAL System Shows Positive One-Year Results in CLASP II TR Trial
Why structural heart devices matter for Edwards: CLASP II TR data on PASCAL and an FDA approval the company reports, plus the safety questions analysts ask.
Why structural heart devices matter for Edwards: CLASP II TR data on PASCAL and an FDA approval the company reports, plus the safety questions analysts ask.